The Effect of Transcranial Direct Current Stimulation on Visual Attention in Mild Cognitive Impairment

Sponsor
Masaryk University (Other)
Overall Status
Recruiting
CT.gov ID
NCT03974087
Collaborator
St. Anne's University Hospital Brno, Czech Republic (Other)
40
1
2
29.3
1.4

Study Details

Study Description

Brief Summary

Progressively causes the breakdown of cognitive functions and impairs quality of life for patients and their caregivers. In addition to memory impairment, visual attention is also compromised, even at the stage of mild cognitive impairment due to AD (MCI-AD). No treatment has been found for MCI-AD; therefore, attention has been drawn to non-invasive brain stimulation techniques, such as transcranial direct current stimulation (tDCS), in order to enhance cognitive functions by modifying brain plasticity. In the current research, investigator aim to examine the long-term effects of the optimal multiple-session tDCS protocol in MCI-AD on visual attention including the transfer to an ecologically valid virtual environment and identify the neural underpinnings of tDCS-induced behavioral aftereffects using a combined tDCS/ MRI network-based approach.

Condition or Disease Intervention/Treatment Phase
  • Device: Transcranial Direct Current Stimulation (tDCS)
N/A

Detailed Description

Investigator will investigate the long-term effects of 10 active tDCS consecutive sessions using an optimized stimulation protocol as compared to a placebo stimulation on visual attention in the MCI-AD. A two-parallel-group, randomized, placebo-controlled design will be used. In addition, the cognitive transfer of tDCS will be evaluated. Repeated tDCS sessions will be performed in 10 consecutive sessions (2 weeks: Monday to Friday) over one preselected ROI together with ongoing visual attention training. During the stimulation, investigator will use the visual matching task. Before the repeated stimulation sessions, participants will undergo the neurocognitive examination. Behavioral examinations of the trained and untrained tasks (i.e. the transfer tasks) will be performed to assess the baseline performance. MRI protocol consisting of T1, T2, FLAIR, and fMRI during the task performance (visual matching task), resting state fMRI, and DTI sequences will be acquired before and after the whole 10-day stimulation protocol in order to search for active vs. placebo tDCS-induced changes in brain activation and resting state functional and structural connectivity and to identify neural correlates of behavioral changes. Behavioral assessment of the trained task and the transfer task will be repeated immediately after and again at a one-month follow-up visit after the end of the last stimulation session

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Transcranial Direct Current Stimulation on Visual Attention in Mild Cognitive Impairment - a Combined MRI and Non-invasive Brain Stimulation Study
Actual Study Start Date :
Feb 19, 2020
Anticipated Primary Completion Date :
Apr 30, 2022
Anticipated Study Completion Date :
Jul 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: MCI patients with real transcranial direct current stimulation

Patients will receive 2mA stimulation in 10 consecutive sessions.

Device: Transcranial Direct Current Stimulation (tDCS)
2mA stimulation for 20 minutes

Sham Comparator: MCI patients with sham transcranial direct current stimulation

Patients will receive sham stimulation in 10 consecutive sessions.

Device: Transcranial Direct Current Stimulation (tDCS)
2mA stimulation for 20 minutes

Outcome Measures

Primary Outcome Measures

  1. Visual-attention task accuracy [Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol]

    Task will be presented on a computer and subject will respond by YES-NO buttons. Only if there are no differences in task accuracy, we will measure task reaction times (e.g. due to the roof effect).

Secondary Outcome Measures

  1. Psychological assessment - z-score computed from multiple psychological domains [Change from baseline immediately after one month from completion of stimulation protocol]

    Z-scores based on neuropsychological assessment (lasting up to 40 min) evaluating (global cognitive functions, memory, attention, psychomotor functions, executive functions, visuospatial functions, language, depressive symptoms, and activities of daily living) Only if there are no changes in z-score, we will asses change on a level of individual tests.

  2. Magnetic resonance imaging [Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol]

    Investigator will record high resolution structural T1-weighted (MPRAGE) images, functional T2* weighted multiband EPI sequences, and DTI measurement. The total time spent in the scanner will be approximately 60 min

Other Outcome Measures

  1. Memory task in virtual reality performance - the accuracy [Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol]

  2. Memory task in virtual reality performance - The time to accomplish different difficulty levels [Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol]

  3. Memory task in virtual reality performance - The trajectories needed for completion of different difficulty levels [Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol]

  4. Visual working memory task accuracy [Change from baseline immediately after completion of stimulation protocol and one month after completion of stimulation protocol]

    Task will be presented on a computer and subject will respond by YES-NO buttons. Only if there are no differences in task accuracy, we will measure task reaction times (e.g. due to the roof effect).

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • amnestic single or multi-domain mild cognitive impairment patients in accordance with diagnostic criteria (Albert et al., 2011)
Exclusion Criteria:
  • psychiatric disorders, including major depression, major vascular lesions, and other brain pathologies detected by MRI that might present with cognitive decline

  • a cardio pacemaker or any MRI-incompatible metal in the body

  • epilepsy

  • any diagnosed psychiatric disorder

  • alcohol/drug abuse

  • lack of cooperation

  • presence of dementia.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ceitec, Masaryk University Brno Czechia 61300

Sponsors and Collaborators

  • Masaryk University
  • St. Anne's University Hospital Brno, Czech Republic

Investigators

  • Principal Investigator: Lubomira Anderková, PhD, Ceitec, Masaryk University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Masaryk University
ClinicalTrials.gov Identifier:
NCT03974087
Other Study ID Numbers:
  • NV18-04-00256
First Posted:
Jun 4, 2019
Last Update Posted:
Apr 6, 2022
Last Verified:
Sep 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Masaryk University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 6, 2022